Search Results - "Salomon, Hervé"
-
1
Immunogenicity and safety of a new liquid hexavalent combined vaccine compared with separate administration of reference licensed vaccines in infants
Published in The Pediatric infectious disease journal (01-12-2000)“…OBJECTIVE.The immunogenicity and safety of a new liquid hexavalent vaccine (diphtheria-tetanus-acellular pertussis-inactivated polio vaccine-hepatitis…”
Get full text
Journal Article -
2
Comparative Efficacy and Safety of Adjuvant Letrozole Versus Anastrozole in Postmenopausal Patients With Hormone Receptor-Positive, Node-Positive Early Breast Cancer: Final Results of the Randomized Phase III Femara Versus Anastrozole Clinical Evaluation (FACE) Trial
Published in Journal of clinical oncology (01-04-2017)“…Purpose The Letrozole (Femara) Versus Anastrozole Clinical Evaluation (FACE) study compared the efficacy and safety of adjuvant letrozole versus anastrozole in…”
Get full text
Journal Article -
3
Phase II Study of BEZ235 versus Everolimus in Patients with Mammalian Target of Rapamycin Inhibitor‐Naïve Advanced Pancreatic Neuroendocrine Tumors
Published in The oncologist (Dayton, Ohio) (01-07-2018)“…Lessons Learned Treatment with BEZ235 has not been shown to demonstrate increased efficacy compared with everolimus and may be associated with a poorer…”
Get full text
Journal Article -
4
Contribution of apo CIII reduction to the greater effect of 12-week micronized fenofibrate than atorvastatin therapy on triglyceride levels and LDL size in dyslipidemic patients
Published in Annals of medicine (Helsinki) (2003)“…Apolipoprotein (apo) CIII plays an important role in the catabolism of triglyceride-rich lipoproteins as it is a potent inhibitor of lipoprotein lipase (LPL)…”
Get more information
Journal Article -
5
A 3-Week Hepatitis B Vaccination Schedule Provides Rapid and Persistent Protective Immunity: A Multicenter, Randomized Trial Comparing Accelerated and Classic Vaccination Schedules
Published in The Journal of infectious diseases (01-07-1995)“…Hepatitis B (HB) vaccinations given once weekly for 3 weeks can provide early seroprotection. This study compared immune responses induced by the accelerated…”
Get full text
Journal Article -
6
Safety and immunogenicity of a recombinant HIV type 1 glycoprotein 160 boosted by a V3 synthetic peptide in HIV-negative volunteers
Published in AIDS research and human retroviruses (01-12-1995)“…The safety and the immunogenicity of a recombinant hybrid envelope glycoprotein MN/LAI (rgp160) followed by booster injections of a V3 (MN) linear peptide were…”
Get more information
Journal Article -
7
Comparison of Micronized Fenofibrate and Pravastatin in Patients With Primary Hyperlipidemia
Published in Journal of cardiovascular pharmacology (01-01-2003)“…Micronized fenofibrate lowers total cholesterol and low-density lipoprotein cholesterol to a similar extent as statins but raises high-density lipoprotein…”
Get full text
Journal Article